BlackRock, Inc. 13D and 13G filings for Arena Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-11 2:13 pm Unchanged |
2021-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA |
BLACKROCK INC BLK |
4,862,407 7.900% |
0 (Unchanged) |
Filing |
| 2022-02-08 5:05 pm Sale |
2021-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA |
BLACKROCK INC BLK |
4,862,407 7.900% |
-528,153 (-9.80%) |
Filing |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA |
BLACKROCK INC BLK |
5,390,560 9.300% |
290,697 (+5.70%) |
Filing |